Literature DB >> 18053467

Prevention, diagnosis, and treatment of cervical cancer.

Harry J Long1, Nadia N I Laack, Bobbie S Gostout.   

Abstract

This article reviews the current data on human papillomavirus as the cause of most cervical cancer cases, data on the recently approved human papillomavirus vaccines, and updated information concerning the Bethesda System for interpretation of Papanicolaou test results. Current recommendations for surgical treatment, concurrent chemotherapy, and radiation therapy and recent advances in systemic therapy for advanced or metastatic cervical cancer are reviewed.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18053467     DOI： 10.1016/S0025-6196(11)61104-X

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


  4 in total

1.  Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.

Authors:  Deirdre R Pachman; Debra L Barton; Amy C Clayton; Renee M McGovern; John A Jefferies; Paul J Novotny; Jeff A Sloan; Charles L Loprinzi; Bobbie S Gostout
Journal:  Am J Obstet Gynecol       Date:  2011-07-13       Impact factor: 8.661

2.  Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines.

Authors:  Shaji K Kumar; Joseph R Mikhael; Francis K Buadi; David Dingli; Angela Dispenzieri; Rafael Fonseca; Morie A Gertz; Philip R Greipp; Suzanne R Hayman; Robert A Kyle; Martha Q Lacy; John A Lust; Craig B Reeder; Vivek Roy; Stephen J Russell; Kristen E Detweiler Short; A Keith Stewart; Thomas E Witzig; Steven R Zeldenrust; Robert J Dalton; S Vincent Rajkumar; P Leif Bergsagel
Journal:  Mayo Clin Proc       Date:  2009-12       Impact factor: 7.616

3.  Development of protocol for the management of cervical cancer symptoms in resource-constrained developing countries.

Authors:  Ramaiah Vinay Kumar; Suman Bhasker
Journal:  Support Care Cancer       Date:  2014-09-16       Impact factor: 3.603

4.  The Clinical Efficacy of Chemotherapy Combined with Traditional Chinese Medicine in the Treatment of Cervical Cancer and Its Influence on Cellular Immunity, Serum CEA, and TNF-α.

Authors:  Qiannan Zhao; Juanjuan Liu; Sai Wang; Xiuqin Wang; Xiufang Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-07       Impact factor: 2.629
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.